SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,578 | -43.5% | 343 | -46.7% | 0.02% | -41.7% |
| Q2 2023 | $73,636 | -16.9% | 643 | 0.0% | 0.04% | -23.4% |
| Q1 2023 | $88,625 | +6.4% | 643 | 0.0% | 0.05% | -2.1% |
| Q4 2022 | $83,320 | +17.4% | 643 | 0.0% | 0.05% | +14.3% |
| Q3 2022 | $71,000 | +16.4% | 643 | -20.7% | 0.04% | +10.5% |
| Q2 2022 | $61,000 | -34.4% | 811 | -32.0% | 0.04% | -17.4% |
| Q1 2022 | $93,000 | -10.6% | 1,193 | +3.0% | 0.05% | -6.1% |
| Q4 2021 | $104,000 | -14.0% | 1,158 | -11.5% | 0.05% | -35.5% |
| Q3 2021 | $121,000 | +23.5% | 1,308 | +4.0% | 0.08% | +26.7% |
| Q2 2021 | $98,000 | +11.4% | 1,258 | +7.1% | 0.06% | -7.7% |
| Q1 2021 | $88,000 | -13.7% | 1,175 | +95.8% | 0.06% | -22.6% |
| Q4 2020 | $102,000 | +21.4% | 600 | 0.0% | 0.08% | +1.2% |
| Q3 2020 | $84,000 | – | 600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |